ATLASCME Group (CME) Q3 2026 earnings results
CME Group (CME) reported EPS of $3.02 against an analyst estimate of $2.98: in line with the estimate (+$0.04 (1.3%)). The quarter ended Sep 30, 2026; the company reported on Wednesday, October 21, 2026, before the open.
Status: Confirmed · cross-checked Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when CME Group reports
Track CME free Add CME Group to a free ATLAS watchlist.
CME Q3 2026 results at a glance
| EPS reported | $3.02 |
|---|---|
| EPS estimate | $2.98 |
| Surprise | In line · +$0.04 (+1.3%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Oct 21, 2026, before the open |
| Status | Confirmed · cross-checked Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is CME Group’s Q3 2026, a calendar-year company.
CME Group EPS surprise history: last 4 quarters
CME Group beat the EPS estimate in 1 of its last 4 reports, with an average surprise of +1.2%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 21, 2026 | $2.98 | $3.02 | +1.3% | In line | +3.6% |
| Jul 22, 2026 | $2.91 | $2.99 | +2.7% | Beat | +7.1% |
| Apr 22, 2026 | $3.37 | $3.36 | -0.3% | In line | +0.4% |
| Feb 4, 2026 | $2.74 | $2.77 | +1.1% | In line | +1.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
CME stock reaction to the report
CME moved +0.16% in the first session that reflects the report (close of Oct 20, 2026 $295.31 to close of Oct 21, 2026 $295.79). Since the report: +3.70% (latest close $306.25 on Nov 2, 2026, against $295.31 before the reaction).
Next CME earnings report
CME Group has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the CME earnings calendar.
ATLAS fair value and signal for CME
| Last price | $306.25 (+1.0%) |
|---|---|
| ATLAS fair value | $338.40 (range $304.56–$372.24) · price is 10% below it |
| Chance of a higher close in 1 month | 52% (normal range $293.30–$321.60) |
These are model outputs from the same valuation and calibrated model as the CME Group stock page. They describe an ordinary period and are not a forecast of any particular outcome.
CME Group Q3 2026 earnings: frequently asked questions
Did CME Group beat earnings estimates for Q3 2026?
CME Group reported EPS of $3.02 against an analyst estimate of $2.98: in line with the estimate (+$0.04 (1.3%)).
When did CME Group report Q3 2026 results?
CME Group reported on Wednesday, October 21, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does CME beat EPS estimates?
In its last 4 reports with a recorded result, CME Group beat the EPS estimate 1 times; the average surprise was +1.2%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer